Overview
Travis Koeneke is a Hematologist Oncology specialist and a Hematologist in Wichita, Kansas. Dr. Koeneke is highly rated in 76 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, and Penile Cancer. Dr. Koeneke is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
Locations
818 N Emporia St, Suite 403, Wichita, KS 67214
9050 E 29th St N, Suite 100, Wichita, KS 67226
8301 Positano Dr, Manhattan, KS 66502
708 N 18th St, Marysville, KS 66508
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Cancer Center Of Kansas PA
Christopher Dakhil is a Hematologist Oncology specialist and a Hematologist in Wichita, Kansas. Dr. Dakhil is highly rated in 42 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer. Dr. Dakhil is currently accepting new patients.
Cancer Center Of Kansas PA
Jeremy Deutsch is a Hematologist Oncology specialist and a Hematologist in Wichita, Kansas. Dr. Deutsch is highly rated in 51 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Familial Colorectal Cancer. Dr. Deutsch is currently accepting new patients.
Cancer Center Of Kansas PA
Nassim Nabbout is a Hematologist Oncology specialist and a Hematologist in Wichita, Kansas. Dr. Nabbout is highly rated in 71 conditions, according to our data. Their top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Lynch Syndrome. Dr. Nabbout is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Koeneke isDistinguished. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaDr. Koeneke isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Colorectal CancerDr. Koeneke isDistinguished. Learn about Colorectal Cancer.
- Endometrial CancerDr. Koeneke isDistinguished. Learn about Endometrial Cancer.
- Familial Colorectal CancerDr. Koeneke isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Wilms Tumor 2Dr. Koeneke isDistinguished. Learn about Familial Wilms Tumor 2.
- Advanced
- Adult Immune ThrombocytopeniaDr. Koeneke isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Koeneke isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Koeneke isAdvanced. Learn about Anal Cancer.
- AnemiaDr. Koeneke isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Koeneke isAdvanced. Learn about Angiosarcoma.
- Appendix CancerDr. Koeneke isAdvanced. Learn about Appendix Cancer.
- Experienced
- Acute Mountain SicknessDr. Koeneke isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Koeneke isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Koeneke isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Koeneke isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.